Identification of a Potential Inhibitor of the FIV p24 Capsid Protein and Characterization of Its Binding Site
- 5 June 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 60 (24) , 1896-1908
Abstract
Feline immunodeficiency virus (FIV) is a veterinary infective agent for which there is currently no efficient drug available. Drugs targeting the lentivirus capsid are currently under development for the treatment of human immunodeficiency virus 1 (HIV-1). Here we describe a lead compound that interacts with the FIV capsid. This compound, 696, modulates the in vitro assembly of and stabilizes the assembled capsid protein. To decipher the mechanism of binding of this compound to the protein, we performed the first nuclear magnetic resonance (NMR) assignment of the FIV p24 capsid protein. Experimental NMR chemical shift perturbations (CSPs) observed after the addition of 696 enabled the characterization of a specific binding site for 696 on p24. This site was further analyzed by molecular modeling of the protein:compound interaction, demonstrating a strong similarity with the binding sites of existing drugs targeting the HIV-1 capsid protein. Taken together, we characterized a promising capsid-interacting compound with a low cost of synthesis, for which derivatives could lead to the development of efficient treatments for FIV infection. More generally, our strategy combining the NMR assignment of FIV p24 with NMR CSPs and molecular modeling will be useful for the analysis of future compounds targeting p24 in the quest to identify an efficient treatment for FIV.Keywords
Funding Information
- Comisi??n Sectorial de Investigaci??n Cient??fica (ID275)
- ECOS-Sud (U14S01)
This publication has 71 references indexed in Scilit:
- Lessons Learned in Developing a Commercial FIV Vaccine: The Immunity Required for an Effective HIV-1 VaccineViruses, 2018
- FIV vaccine with receptor epitopes results in neutralizing antibodies but does not confer resistance to challengenpj Vaccines, 2018
- The Comparative Value of Feline Virology Research: Can Findings from the Feline Lentiviral Vaccine Be Translated to Humans?Veterinary Sciences, 2017
- FELINE IMMUNODEFICIENCY VIRUS AND FELINE LEUKEMIA VIRUS INFECTION IN FREE-RANGING GUIGNAS (LEOPARDUS GUIGNA) AND SYMPATRIC DOMESTIC CATS IN HUMAN PERTURBED LANDSCAPES ON CHILOÉ ISLAND, CHILEJournal of Wildlife Diseases, 2015
- Pharmacological Inhibition of Feline Immunodeficiency Virus (FIV)Viruses, 2012
- Emerging Viruses in the Felidae: Shifting ParadigmsViruses, 2012
- Feline immunodeficiency virus (FIV) in wild Pallas’ catsVeterinary Immunology and Immunopathology, 2010
- Pathological manifestations of feline immunodeficiency virus (FIV) infection in wild African lionsVirology, 2009
- Seroprevalence and Genomic Divergence of Circulating Strains of Feline Immunodeficiency Virus among Felidae and Hyaenidae SpeciesJournal of Virology, 2005
- Isolation of a T-Lymphotropic Virus from Domestic Cats with an Immunodeficiency-Like SyndromeScience, 1987